Overview

Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Pediatric Patients >3 to 17 Years of Age Requiring Long-term Parenteral Nutrition

Status:
Not yet recruiting

Trial end date:
2026-12-04

Target enrollment:

Participant gender:

Summary

Tralement versus a fixed-dose trace element combination product of zinc, copper, and selenious acid to evaluate product safety in pediatric patients >3 to 17 years of age requiring long-term parenteral nutrition.

Phase:

Phase 4

Details

Lead Sponsor:

American Regent, Inc.

Treatments:

Copper
Micronutrients
Selenious Acid
Trace Elements